Intercellular Adhesion Molecule 1 (ICAM-1 or CD54), a surface receptor known to be upregulated in MM, is associated with poor prognosis and resistance to chemotherapy [55,56,57,58,59]. The gene discussed is ICAM1; the disease is Miyoshi myopathy.